BioMarin adds Bristol Myers Squibb research chief to its board
Go back to BioMarin adds Bristol Myers Squibb research chief to its board| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.37 -0.69 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.06 | 52 Week High | $108.96 | |||
| Open | $64.34 | 52 Week Low | $62.12 | |||
| Day High | $64.79 | P/E | N/A | |||
| Day Low | $63.35 | EPS | $-1.27 | |||
| Volume | 1,962,553 | |||||
